https://www.avient.com/industries/healthcare/drug-delivery-systems/prefilled-syringes
Learn more about how Avient's medical-grade polymers, colorants and additives can enhance effectiveness and safety.
https://www.avient.com/industries/healthcare/medical-devices-equipment/rehabilitation-equipment
Learn how composite springs provide flexibility in prosthetic performance and design
https://www.avient.com/products/advanced-composites/pultrusion-and-continuous-filament-winding-technology/gridcore-composite-utility-poles
Case Study Modular Ballistic Protection Made Possible with Composites
Learn how Southern States Supplier used GlasArmor™ ballistic panels to protect electrical substations.
https://www.avient.com/products/engineered-polymer-formulations/flame-retardant-formulations/maxxam-fr-flame-retardant-formulations-and-maxxam-nhfr-non-halogen-flame-retardant-formulations
Overview of how Avient serves wire & cable customers, highlighting both power and data cables technologies
https://www.avient.com/sites/default/files/2022-04/Avient Q1 2022 Earnings Release.pdf
Three Months Ended
March 31,
2022 2021
Sales:
Color, Additives and Inks $ 649.5 $ 609.3
Specialty Engineered Materials 244.7 216.5
Distribution 432.9 362.7
Corporate and eliminations (33.3) (26.2)
Sales $ 1,293.8 $ 1,162.3
Gross margin:
Color, Additives and Inks $ 192.1 $ 197.5
Specialty Engineered Materials 69.8 64.7
Distribution 39.3 39.3
Corporate and eliminations (7.5) 0.9
Gross margin $ 293.7 $ 302.4
Selling and administrative expense:
Color, Additives and Inks $ 97.6 $ 108.7
Specialty Engineered Materials 30.1 30.5
Distribution 15.1 15.3
Corporate and eliminations 22.3 27.5
Selling and administrative expense $ 165.1 $ 182.0
Operating income:
Color, Additives and Inks $ 94.5 $ 88.8
Specialty Engineered Materials 39.7 34.2
Distribution 24.2 24.0
Corporate and eliminations (29.8) (26.6)
Operating income $ 128.6 $ 120.4
Earnings before interest, taxes, depreciation and amortization (EBITDA):
Color, Additives and Inks $ 120.5 $ 116.2
Specialty Engineered Materials 47.5 42.0
Distribution 24.4 24.2
Corporate and eliminations (26.0) (24.9)
Other income, net (0.6) 1.5
EBITDA $ 165.8 $ 159.0
11
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current profitability
levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/2023-05/AVNT Q1 2023 Earnings Presentation.pdf
Senior management also uses operating income before
special items to assess performance and allocate resources because senior management believes that these measures are
useful in understanding current profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
Senior management also uses operating income before
special items to assess performance and allocate resources because senior management believes that these measures are
useful in understanding current profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/2024-05/AVNT Q1 2024 Investor Presentation_website w Non-GAAP.pdf
Senior management also uses operating income before
special items to assess performance and allocate resources because senior management believes that these measures are
useful in understanding current profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
Senior management also uses operating income before
special items to assess performance and allocate resources because senior management believes that these measures are
useful in understanding current profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/resources/Polyone%2520AR.pdf
Purchases of common shares may be made by open market purchases or privately negotiated
transactions and may be made pursuant to Rule 10b5-1 plans and accelerated share repurchases.
As a result, we did not recognize a cumulative effect
adjustment to the opening balance of retained earnings.
Neither of those documents contemplates who is responsible for remediation or how such costs might be allocated to
PRPs.